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Summary
Queen mandibular pheromone (QMP) is produced by honey
bee queens and used to regulate the behavior and physiology
of their nestmates [1]. QMP has recently been shown to block
aversive learning in young worker bees, an effect that can be
mimicked by treating bees with one of QMP’s key compo-
nents, homovanillyl alcohol (HVA) [2]. Although the mecha-
nisms underlying this blockade remain unclear, HVA has
been found to lower brain dopamine levels and to alter intra-
cellular levels of cAMP in brain centers involved in learning
and memory [3]. These findings led to the hypothesis that
HVA targets dopamine pathways in the brain [3], which are
known to play a critical role in the formation of aversive olfac-
tory memories [4–8]. Here, we investigate the possibility that
HVA interacts directly with dopamine receptors in the bee.
We show that HVA selectively activates the D2-like dopamine
receptor AmDOP3 but has neither agonist nor antagonist
activity on the D1-like receptors AmDOP1 or AmDOP2 nor
agonist activity on the octopamine receptor AmOA1. These
results suggest a direct molecular mechanism by which
queen pheromone can modulate dopamine signaling path-
ways. They also implicate the dopamine receptor AmDOP3
in HVA-induced blockade of aversive learning in young
worker bees.
Results and Discussion
HVA Is Not an AmDOP1 or AmDOP2 Receptor Agonist
AmDOP1 andAmDOP2 receptors in honey bees are G protein-
coupled receptors that share an important property with the
D1-like family of dopamine receptors in vertebrates: activation
of these receptors increases levels of the intracellular signaling
molecule cAMP [9–11]. HEK293 cells transfected with an
AmDOP1 or AmDOP2 expression construct, together with
a cAMP response element (CRE)-luciferase reporter construct,
were used to examine whether homovanillyl alcohol (HVA)
acts as an AmDOP1 or AmDOP2 receptor agonist. Consistent
with earlier studies [9–11], we found that dopamine causes
a dose-dependent increase in intracellular cAMP levels in
cells expressing either AmDOP1 receptors (Figure 1A, B) or
AmDOP2 receptors (Figure 1B,B). However, HVA at concen-
trations of up to 100 mM had no significant effect on cAMP
levels in these cells (Figures 1A and 1B,d).
To verify these findings, we expressed AmDOP1 and
AmDOP2 also in Spodoptera frugiperda (Sf21) cells (an insect
cell line) and measured intracellular cAMP levels directly in
control (untreated) cells and in cells exposed to either 10 mM
dopamine or 10 mM HVA. Whereas dopamine treatment
caused robust elevation of cAMP in AmDOP1- and AmDOP2-
*Correspondence: alison.mercer@stonebow.otago.ac.nzexpressing cells (Figures 1C and 1D, respectively), HVA had
no significant effect on intracellular cAMP levels, nor did it
block the effects of dopamine on these cells (Figures 1C and
1D). These results indicate that HVA has no significant agonist
or antagonist activity on the D1-like dopamine receptors
AmDOP1 and AmDOP2.
HVA Activates the AmDOP3 Receptor
AmDOP3 receptor activation generally leads to a reduction in
cAMP levels [12], a feature characteristic of D2-like dopamine
receptors [13]. However, recent evidence suggests that
coupling of AmDOP3 with cAMP can vary depending on the
cellular environment [14]. To determine whether HVA targets
the AmDOP3 receptor and, if so, whether it leads to an
increase or decrease in cAMP levels, we expressed AmDOP3
in HEK293 cells and used a CRE-luciferase reporter to monitor
changes in intracellular cAMP. Interestingly, not only dopa-
mine but also HVA elicited a dose-dependent inhibitory effect
on cAMP levels in AmDOP3-expressing cells (Figure 2A). HVA
was approximately 80-fold less potent than the native ligand
(dopamine EC50 = 0.12 mM; HVA EC50 = 9.6 mM). To confirm
HVA’s agonist activity on theAmDOP3 receptor, we expressed
AmDOP3 inSf21 cells also and treated the cells with dopamine
or HVA. Both ligands caused a significant reduction in intracel-
lular cAMP levels in AmDOP3-expressing cells (Figure 2B).
How Specific Are HVA’s Effects?
HVA’s ability to activate the dopamine receptor AmDOP3 is
consistent with studies showing that AmDOP3 receptors are
expressed by intrinsic mushroom body neurons [12] and that
HVA applied to mushroom bodies of the bee brain mimics
the effects of exogenously applied dopamine [3], but how
specific are HVA’s effects? Octopamine receptors have also
been identified in mushroom bodies of the insect brain [15,
16], and in bees, as in other insects, octopamine has been
strongly implicated in the formation of appetitive memories
[4, 17–19]. To date, only one of several putative octopamine
receptors has been cloned and characterized in the bee,
AmOA1, activation of which is reported to increase intracel-
lular levels of cAMP [15]. We found that in HEK293 cells
expressing AmOA1 receptors, octopamine caused a dose-
dependent upregulation of cAMP (Figure 3). HVA, on the other
hand, had no agonist activity in AmOA1-expressing cells.
Although we cannot rule out the possibility that HVA interacts
with receptors other than AmDOP3, these results add weight
to the view that HVA’s actions are selective for AmDOP3.
AmDOP3 Receptor Coupling to cAMP
Responses to dopamine and HVA have been shown to vary
depending on whether or not bees have been exposed during
early adulthood to queen mandibular pheromone (QMP) [3].
In young bees exposed to QMP, HVA or dopamine applied
exogenously to calycal regions of the mushroom bodies
causes cAMP levels in the tissues to fall, whereas in young
bees that have never been exposed to QMP, cAMP levels rise
in response to exogenously applied HVA or dopamine [3]. If
HVA acts selectively at AmDOP3 receptors, how might these
results be explained? Clark and Baro have shown that in
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1207Figure 1. Homovanillyl Alcohol Shows No
Agonist Activity on the D1-like Dopamine Recep-
tors AmDOP1 and AmDOP2
(A and B) HEK293 cells expressing either
AmDOP1 receptors (A) or AmDOP2 receptors
(B) show a dose-dependent increase in intracel-
lular cAMP levels in response to dopamine, but
not in response to homovanillyl alcohol (HVA).
Data are means 6 SEM of three independent
experiments.
(C and D) Intracellular cAMP levels in Sf21 cells
expressing AmDOP1 receptors (C) or AmDOP2
receptors (D). Dopamine (10 mM) increases
cAMP levels inAmDOP1- andAmDOP2-express-
ing cells, whereas HVA (10 mM) has no effect on
cAMP levels in these cells, nor does it block
the response to 10 mM dopamine. Values are
means 6 SEM obtained from three independent
experiments. Overall statistical significance was
determined by one-way ANOVA followed by
Tukey-Kramer tests. Letters above each bar indi-
cate the significance of differences between
groups. Groups that share a letter are not signif-
icantly different. F3,8 = 67.89, p < 0.0001 for (C);
F3.8 = 25.99, p = 0.0002 for (D).arthropods, activation of D2-like dopamine receptors, includ-
ing AmDOP3, can lead to either an increase or a decrease in
intracellular levels of cAMP [14]. Their evidence suggests that
not only the Ga subunit but also the Gbg subunits of the Gi/o
proteins that couple to AmDOP3 receptors can contribute to
dopamine-induced alterations in intracellular cAMP levels;
Ga-mediated inhibition of adenylyl cyclase leads to a decrease
in cAMP, whereas Gbg-mediated stimulation of phospholipase
C leads to activation of adenylyl cyclase and an increase in
cAMP levels [14]. Similar findings have been reported also for
mammalian D2 receptors [20, 21], and shifts in coupling have
been attributed to differences in the intracellular signaling envi-
ronment [14, 20]. Because QMP has wide-ranging effects on
gene expression levels in the brain [22], it is tempting to spec-
ulate that one outcome of this is a change in the intracellular
environment that influences the functioning of AmDOP3. Clark
and Baro’s findings [14], together with our studies in the bee [3],
would predict that in the brains of young bees exposed to QMP
early in adult life, the intracellular environment favorsAmDOP3
coupling with cAMP through Ga-mediated pathways, whereas
in young bees that have never been exposed to this phero-
mone,AmDOP3 coupling to cAMP via Gbg-mediated pathways
may be favored. Although this remains speculation, the possi-
bility that QMP influencesAmDOP3 receptor coupling to cAMP
warrants further attention, because shifts in receptor function
could potentially have profound effects not only on brain func-
tion but also on the behavior of the bee. The potential for
chemical modulators to alter the function of neural circuits
and ultimately behavior itself has been demonstrated elegantly
in other systems, in particular the stomatogastric nervous
system of lobsters and crabs [23].
The results of our study lend support to the hypothesis that
HVA targets dopamine pathways in the bee. We have shown in
previous studies that HVA reduces brain dopamine levels and
alters intracellular levels of cAMP in brain centers (mushroom
bodies) involved in learning and memory [3]. Taken together
with evidence showing that intrinsic mushroom body neurons
(Kenyon cells) express Amdop3 [12], HVA’s selective effectson AmDOP3 receptor function suggest that this D2-like dopa-
mine receptor is likely to be involved in HVA-induced blockade
of aversive learning in young worker bees, a finding consistent
with the growing body of evidence that dopamine plays a crit-
ical role in aversive memory formation in insects.
Experimental Procedures
Luciferase Reporter Assays
Receptor coupling to cAMP was assessed indirectly via a CRE-luciferase
reporter [24]. Luciferase assays were performed in HEK293 cells maintained
as adherent cultures at 37C/5% CO2 in phenol red-free DMEM/F12 medium
supplemented with 10% fetal calf serum (Invitrogen). Exponentially growing
cells were dispensed at a density of 2 3 104 cells per well in 96-well, white-
walled, clear-bottomed tissue culture plates (Greiner Bio-One) and allowed
to grow for 24 hr. The cells were cotransfected with a receptor expression
construct (see the Supplemental Experimental Procedures available online)
together with the pGL4.29[luc2P/CRE/Hygro] reporter construct (Promega)
via FuGENE HD reagent (Roche). Transfected cells were maintained for
a further 24 hr at 37C prior to assaying for receptor function. Growth
medium was carefully aspirated from the cells and immediately replaced
with 100 ml of serum-free DMEM/F12 alone or DMEM/F12 containing HVA,
dopamine hydrochloride, or DL-octopamine hydrochloride (Sigma-Aldrich)
at the concentrations indicated in the figure legends. For analysis of
responses in cells expressing AmDOP3, forskolin (100 nM) was also added
to the medium to increase the basal level of cAMP. Addition of forskolin at
this concentration does not drive adenylate cyclase activity to saturation,
and increases in cAMP levels, if they were to occur, would therefore still
be detectable under these conditions. Cells were incubated for 3 hr and
then assayed for luciferase enzyme activity with Steady-Glo reagent (Prom-
ega). Luminescence signal was detected with a BMG FLUOstar Omega
microplate instrument.
Competitive Enzyme Immunoassays for cAMP
Receptor coupling to cAMP was assessed directly via competitive enzyme
immunoassays. Assays were performed with Spodoptera frugiperda (Sf21)
cells, which were maintained as suspension cultures at 28C in Sf900II
medium (Invitrogen). Exponentially growing cells were dispensed at
a density of 2.5 3 105/well in 24-well plates (Greiner Bio-One) and allowed
to adhere for 1 hr. Expression plasmid constructs (see Supplemental Exper-
imental Procedures) were transfected into the cells via FuGENE6 reagent
(Roche), and the cells were maintained for a further 48 hr prior to assaying
for receptor function. Cells transfected with pIB/V5-His-GW/LacZ for
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controls.
Measurements of intracellular cAMP were used to assess the effects of
dopamine and HVA on Sf21 cells expressing honey bee receptor proteins
and on control cells expressing b-Gal protein. Growth medium was removed
and replaced with fresh serum-free growth medium containing 100 mM
3-isobutyl-1-methylxanthine (IBMX) alone or with dopamine or HVA. For
analysis of responses in Sf21 cells expressing the D2-like receptor
AmDOP3, forskolin (10 mM) was added to the medium to increase basal
cAMP levels. Cells were exposed for 20 min to dopamine or HVA at the
concentrations indicated in the figure legends. Intracellular cAMP levels
were measured immediately after treatment via a Biotrak competitive
enzyme immunoassay (GE Healthcare).
Data Analysis
One-way ANOVA followed by Tukey-Kramer tests for post hoc analysis was
used to compare responses to different treatments in Sf21 cells expressing
the same receptor. Equality of variance and normality of data were confirmed
via Levene and Shapiro-Wilk tests, respectively. For comparing cAMP levels
in Sf21 cells expressing AmDOP3 versus b-Gal, Student’s two-tailed t test
was used. EC50 values were calculated from concentration response curves
with the sigmoidal dose-response (variable slope) analysis program Graph-
Pad Prism version 5.0b for Macintosh.
Figure 2. HVA Acts as an Agonist at the D2-like Dopamine Receptor
AmDOP3
(A) HEK293 cells expressing AmDOP3 receptors show a dose-dependent
decrease in intracellular cAMP in response to treatment with either dopa-
mine or HVA. Data are means 6 SEM of three independent experiments.
Statistical significance was determined via Student’s two-tailed t test.
(B) Effects of HVA and dopamine on Sf21 cells expressing either AmDOP3
receptors (white bars) or b-galactosidase (b-Gal) protein (gray bars). Dopa-
mine (10 mM) causes a significant decrease in intracellular cAMP levels in
AmDOP3-expressing cells (p = 0.0004). Treatment with 10 mM HVA also
decreases cAMP levels in these cells (p = 0.0034). Data are expressed as
a percentage of forskolin-stimulated cAMP levels in controls. Data are
means6SEMof eight independentexperiments.Asterisks denotesignificant
differences between AmDOP3-expressing cells and b-Gal-expressing cells
exposed to the same ligand, as determined via Student’s two-tailed t test.All experiments described in this work comply with the laws of New Zea-
land regulating scientific research.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures and can
be found with this article online at http://www.cell.com/current-biology/
supplemental/S0960-9822(09)01186-5.
Acknowledgments
We would like to thank Vernon Ward for donation of the Sf21 cell line and
Brian Niven for advice on statistical methods. This research was supported
by grants UOO312 and UOO0615 from the Royal Society of New Zealand
Marsden Fund.
Received: April 4, 2009
Revised: May 1, 2009
Accepted: May 15, 2009
Published online: June 11, 2009
References
1. Slessor, K.N., Winston, M.L., and Le Conte, Y. (2005). Pheromone
communication in the honeybee (Apis mellifera L.). J. Chem. Ecol. 31,
2731–2745.
2. Vergoz, V., Schreurs, H.A., and Mercer, A.R. (2007). Queen pheromone
blocks aversive learning in young worker bees. Science 317, 384–386.
3. Beggs, K.T., Glendining, K.A., Marechal, N.M., Vergoz, V., Nakamura, I.,
Slessor, K.N., and Mercer, A.R. (2007). Queen pheromone modulates
brain dopamine function in worker honey bees. Proc. Natl. Acad. Sci.
USA 104, 2460–2464.
4. Schwaerzel, M., Monastirioti, M., Scholz, H., Friggi-Grelin, F., Birman,
S., and Heisenberg, M. (2003). Dopamine and octopamine differentiate
between aversive and appetitive olfactory memories in Drosophila.
J. Neurosci. 23, 10495–10502.
5. Riemensperger, T., Voller, T., Stock, P., Buchner, E., and Fiala, A. (2005).
Punishment prediction by dopaminergic neurons in Drosophila. Curr.
Biol. 15, 1953–1960.
6. Schroll, C., Riemensperger, T., Bucher, D., Ehmer, J., Vo¨ller, T., Erbguth,
K., Gerber, B., Hendel, T., Nagel, G., Buchner, E., et al. (2006). Light-
induced activation of distinct modulatory neurons triggers appetitive
or aversive learning in Drosophila larvae. Curr. Biol. 16, 1741–1747.
7. Unoki, S., Matsumoto, Y., and Mizunami, M. (2005). Participation of
octopaminergic reward system and dopaminergic punishment system
in insect olfactory learning revealed by pharmacological study. Eur.
J. Neurosci. 22, 1409–1416.
8. Vergoz, V., Roussel, E., Sandoz, J.C., and Giurfa, M. (2007). Aversive
learning in honeybees revealed by the olfactory conditioning of the sting
extension reflex. PLoS ONE 2, e288.
9. Blenau, W., Erber, J., and Baumann, A. (1998). Characterization of
a dopamine D1 receptor from Apis mellifera: Cloning, functional
Figure 3. HVA Has No Activity on the Octopamine Receptor AmOA1
HEK293 cells expressing AmOA1 receptors show a dose-dependent
increase in intracellular cAMP in response to octopamine but do not
respond to HVA. Data are means6 SEM of three independent experiments.
Receptor Activation by Queen Bee Pheromone
1209expression, pharmacology, and mRNA localization in the brain.
J. Neurochem. 70, 15–23.
10. Humphries, M.A., Mustard, J.A., Hunter, S.J., Mercer, A., Ward, V., and
Ebert, P.R. (2003). Invertebrate D2 type dopamine receptor exhibits
age-based plasticity of expression in the mushroom bodies of the
honeybee brain. J. Neurobiol. 55, 315–330.
11. Mustard, J.A., Blenau, W., Hamilton, I.S., Ward, V.K., Ebert, P.R., and
Mercer, A.R. (2003). Analysis of two D1-like dopamine receptors from
the honey beeApismellifera reveals agonist-independent activity. Brain
Res. Mol. Brain Res. 113, 67–77.
12. Beggs, K.T., Hamilton, I.S., Kurshan, P.T., and Mustard, J.A. (2005).
Characterization of a D2-like dopamine receptor (AmDOP3) in honey
bee, Apis mellifera. Insect Biochem. Mol. Biol. 35, 873–882.
13. Missale, C., Nash, S.R., Robinson, S.W., Jaber, M., and Caron, M.G.
(1998). Dopamine receptors: From structure to function. Physiol. Rev.
78, 189–225.
14. Clark, M.C., and Baro, D.J. (2007). Arthropod D2 receptors positively
couple with cAMP through the Gi/o protein family. Comp. Biochem.
Physiol. B Biochem. Mol. Biol. 146, 9–19.
15. Grohmann, L., Blenau, W., Erber, J., Ebert, P.R., Strunker, T., and
Baumann, A. (2003). Molecular and functional characterization of an
octopamine receptor from honeybee (Apis mellifera) brain. J. Neuro-
chem. 86, 725–735.
16. Roeder, T. (2005). Tyramine and octopamine: Ruling behavior and
metabolism. Annu. Rev. Entomol. 50, 447–477.
17. Hammer, M. (1993). An identified neuron mediates the unconditioned
stimulus in associative olfactory learning in honeybees. Nature 366,
59–63.
18. Hammer, M., and Menzel, R. (1998). Multiple sites of associative odor
learning as revealed by local brain microinjections of octopamine in
honeybees. Learn. Mem. 5, 146–156.
19. Farooqui, T., Vaessin, H., and Smith, B.H. (2004). Octopamine receptors
in the honeybee (Apis mellifera) brain and their disruption by RNA-
mediated interference. J. Insect Physiol. 50, 701–713.
20. Tsu, R.C., and Wong, Y.H. (1996). Gi-mediated stimulation of type II
adenylyl cyclase is augmented by Gq-coupled receptor activation and
phorbol ester treatment. J. Neurosci. 16, 1317–1323.
21. Hernandez-Lopez, S., Tkatch, T., Perez-Garci, E., Galarraga, E., Bargas,
J., Hamm, H., and Surmeier, D.J. (2000). D2 dopamine receptors in stria-
tal medium spiny neurons reduce L-type Ca2+ currents and excitability
via a novel PLCb1-IP3-calcineurin-signaling cascade. J. Neurosci. 20,
8987–8995.
22. Grozinger, C.M., Sharabash, N.M., Whitfield, C.W., and Robinson, G.E.
(2003). Pheromone-mediated gene expression in the honey bee brain.
Proc. Natl. Acad. Sci. USA 100, 14519–14525.
23. Marder, E., and Buchner, D. (2007). Understanding circuit dynamics
using the stomatogastric nervous system of lobsters and crabs. Annu.
Rev. Physiol. 69, 291–316.
24. Hill, S.J., Baker, J.G., and Rees, S. (2001). Reporter-gene systems for
the study of G-protein-coupled receptors. Curr. Opin. Pharmacol. 1,
526–532.
